South Africa, Eswatini and Zambia have launched the first public distribution of lenacapavir, a revolutionary HIV-prevention injection shown to reduce transmission risk by over 99.9 percent. The rollout, supported by global health agencies and aimed at regions with the world’s highest HIV infection rate, marks a major step forward in HIV prevention, even as advocates urge broader access and lower pricing.
Check Also
JOJ Dakar 2026 : Quatre questions à Clarisse Agbegnenou, athlète modèle des Jeux
À l’occasion des Jeux Olympiques de la Jeunesse 2026 qui se déroulent à Dakar, …
Le portail de L'Afrique Les Dernières nouvelles Africaines